Edwards Lifesciences EW
NYSE EW
$86.27 -0.45 (-0.52%)
As of: Sep 9, 2026 · 12:54 PM EDT

Edwards Lifesciences (EW) Free Cash Flow Growth (5y) (2014 - 2026)

Analysis

Edwards Lifesciences (EW) Free Cash Flow Growth (5y) (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 183.86 Bn 178.25 Bn 7.27 Bn
2 Intuitive Surgical 124.18 Bn 118.97 Bn 1.96 Bn
3 Medtronic 118.18 Bn 109.36 Bn 6.34 Bn
4 Stryker 104.54 Bn 101.07 Bn 4.50 Bn
5 Boston Scientific 66.34 Bn 65.80 Bn 3.85 Bn
6 Edwards Lifesciences 49.64 Bn 45.39 Bn 1.35 Bn
7 Alcon 33.93 Bn 32.47 Bn 1.68 Bn
8 Dexcom 32.20 Bn 30.25 Bn 830.00 Mn
9 Steris 21.14 Bn 20.66 Bn 684.20 Mn
10 Zimmer Biomet Holdings 18.11 Bn 17.70 Bn 1.54 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.07%
Mar 31, 2026 -16.09%
Dec 31, 2025 4.29%
Sep 30, 2025 35.55%
Jun 30, 2025 14.39%
Mar 31, 2025 12.43%
Dec 31, 2024 -20.45%
Sep 30, 2024 -3.65%
Jun 30, 2024 0.68%
Mar 31, 2024 -23.89%
Dec 31, 2023 -27.14%
Sep 30, 2023 6.73%
Jun 30, 2023 -16.69%
Mar 31, 2023 18.50%
Dec 31, 2022 -7.27%
Sep 30, 2022 -1.42%
Jun 30, 2022 15.66%
Mar 31, 2022 14.44%
Dec 31, 2021 15.53%
Sep 30, 2021 24.46%